Literature DB >> 25868951

Stenosing ureteritis in Henoch-Schönlein purpura: report of two cases.

Katsuaki Kasahara1, Osamu Uemura, Takuhito Nagai, Satoshi Yamakawa, Masaru Nakano, Naoyuki Iwata.   

Abstract

Stenosing ureteritis (SU), a rare complication of Henoch-Schönlein purpura (HSP), typically presents with severe symptoms. We report the cases of two HSP patients presenting with gross hematuria, blood clotting, and colicky flank pain, followed by purpura on the lower extremities. Early-stage ultrasonography indicated hydronephrosis, thickened renal pelvic mucous membrane, and ureteral dilatation (UD), suggesting HSP complicated with SU. After early SU treatment with prednisolone, kidney function, thickened renal pelvic mucous membrane, and UD progressively normalized and the pain gradually disappeared. Regular ultrasonography of HSP patients from the onset of gross hematuria can be useful to detect early SU and facilitate conservative therapy with prednisolone. Diagnosis of SU can be easily missed by assuming HSP nephritis, particularly owing to the non-specific symptoms. Common characteristics as well as treatment methods and prognosis of SU are given in the literature review.
© 2015 Japan Pediatric Society.

Entities:  

Keywords:  Henoch-Schönlein purpura; Henoch-Schönlein purpura nephritis; gross hematuria; hydronephrosis; stenosing ureteritis; ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 25868951     DOI: 10.1111/ped.12471

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  2 in total

1.  A boy with IgA vasculitis and anuria: Answers.

Authors:  Vivek Sharma; Sidharth Kumar Sethi; Rupesh Raina; Shyam Bansal; S S Baijal; Vijay Kher
Journal:  Pediatr Nephrol       Date:  2019-11-26       Impact factor: 3.714

2.  Henoch-Schönlein Purpura /IgA Vasculitis Complicated by Coronary Artery Aneurysm: A Case Report and Literature Review.

Authors:  Zhijuan Kang; Wentao Wu; Mai Xun; Yunfeng Ding; Zhihui Li
Journal:  Front Pediatr       Date:  2022-02-03       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.